Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02284568
Brief Title: A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo (ARPEGGIO)

First Submitted : October 31, 2014
First Submitted that Met QC Criteria : November 3, 2014
First Posted : November 6, 2014 (Estimate)

Results First Submitted : August 16, 2018
Results First Submitted that Met QC Criteria : October 2, 2018
Results First Posted : November 2, 2018

Certification/Extension First Submitted : May 9, 2018
Certification/Extension First Submitted that Met QC Criteria : May 9, 2018
Certification/Extension First Posted : May 11, 2018

Last Update Submitted that Met QC Criteria : October 2, 2018
Last Update Posted : November 2, 2018